Clinical Research Directory

Inclusion Criteria (Participants must meet all of the following criteria to be eligible) * Age: ≥18 years old. * Diagnosis: Patients undergoing ureteral stenting post-ureteroscopy for uric acid kidney stones. * Urinary pH: ≤5.5 at baseline (acidic urine). * Willingness to Participate: Patients who provide informed consent to participate in the study. Exclusion Criteria (Participants will be excluded if they meet any of the following criteria) Renal Function: Patients with significantly impaired kidney function (elevated creatinine beyond normal limits). Infections: History of febrile urinary tract infection (UTI) at the time of enrollment. Metabolic Disorders: Chronic kidney disease (CKD) Stage 3 or higher. History of hyperkalemia. Pregnancy: Pregnant or breastfeeding women. Residual Stones: Patients with residual stone burden after ureteroscopy that may confound outcomes. Medication Interference: Patients on medications that significantly alter urinary pH (e.g., sodium bicarbonate, acetazolamide) or those contraindicated with potassium citrate. Other Severe Comorbidities: Any condition that, in the investigator's judgment, would interfere with study participation or pose excessive risk.